Management of DKA
Reading File
Searching for DKA management across key domains in parallel.
search_medical_text
diabetic ketoacidosis DKA management treatment protocol fluids insulin
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 11347
search_medical_text
DKA diagnosis criteria complications monitoring electrolytes potassium
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 11350
GradeResponse
GradeResponse
Both results are from Harrison's. The first covers the treatment overview and the second covers potassium management in detail. Let me synthesize a comprehensive answer.
Management of Diabetic Ketoacidosis (DKA)
Diagnostic Criteria
| Parameter | Mild | Moderate | Severe |
|---|---|---|---|
| Blood glucose | >250 mg/dL | >250 mg/dL | >250 mg/dL |
| Arterial pH | 7.25–7.30 | 7.00–7.24 | <7.00 |
| Serum bicarbonate | 15–18 mEq/L | 10–15 mEq/L | <10 mEq/L |
| Anion gap | >10 | >12 | >12 |
| Urine/serum ketones | Positive | Positive | Positive |
| Mental status | Alert | Alert/drowsy | Stupor/coma |
Immediate Assessment
- Vital signs, GCS, weight
- Labs: BMP/CMP, blood gas (venous acceptable), CBC, phosphate, magnesium, urinalysis, urine/serum ketones, HbA1c, cultures if infection suspected
- ECG (hyperkalemia/hypokalemia may be life-threatening)
- Identify and treat the precipitating cause: infection (most common), insulin omission, new-onset T1DM, MI, pancreatitis, medications (steroids, SGLT2i)
- Insert NGT if vomiting or altered mental status to prevent aspiration (Harrison's, p. 11347)
Treatment Protocol
1. IV Fluid Resuscitation
Priority: Restore intravascular volume, correct hyperosmolality, improve renal perfusion.
| Phase | Fluid | Rate |
|---|---|---|
| Initial (first 1–2 h) | 0.9% NaCl | 1–1.5 L/h |
| Subsequent | 0.45% NaCl (if corrected Na normal/high) or 0.9% NaCl (if corrected Na low) | 250–500 mL/h |
| When glucose reaches ~200 mg/dL | Switch to D5W + 0.45% NaCl | Titrate to maintain glucose 150–200 mg/dL |
- Typical total deficit: 3–6 L (replace over 24–48 h)
- Avoid overly rapid correction — can precipitate cerebral edema (especially in children)
2. Insulin Therapy
- Do NOT start insulin until K⁺ ≥ 3.5 mEq/L — insulin drives K⁺ intracellularly and can cause life-threatening hypokalemia
- Regular insulin IV infusion: 0.1 units/kg/h (some protocols use a 0.1 units/kg IV bolus first)
- Target blood glucose fall: 50–75 mg/dL/h
- If glucose not falling by 50–75 mg/dL in first hour, double the infusion rate
- When glucose reaches ~200 mg/dL: reduce insulin to 0.02–0.05 units/kg/h and add dextrose to IV fluids
- Continue insulin infusion until DKA resolved (not until glucose normalizes alone) — resolution criteria: glucose <200, bicarb ≥15, pH >7.3, anion gap closed
- Transition to subcutaneous insulin: overlap IV and SC insulin by 1–2 hours to avoid rebound ketosis; give first SC dose before stopping drip
3. Potassium Replacement
(Harrison's, p. 11350)
Potassium stores are depleted by an estimated 3–5 mmol/kg in DKA, even when serum K⁺ appears normal or elevated (due to transcellular shift from acidosis).
| Serum K⁺ (mEq/L) | Action |
|---|---|
| <3.5 | Hold insulin; give 20–40 mEq/h IV K⁺ until ≥3.5, then start insulin |
| 3.5–5.0 | Add 20–40 mEq K⁺ per liter of IV fluid |
| >5.0 | Hold K⁺ replacement; check every 2 hours |
- Goal: maintain K⁺ >3.5 mEq/L throughout treatment
- Can use potassium phosphate or potassium acetate to reduce chloride load
4. Bicarbonate
- Generally NOT recommended for most patients — may paradoxically worsen CNS acidosis and hypokalemia, impair oxygen delivery (left-shift oxyhemoglobin curve)
- Consider if: pH <6.9, severe hyperkalemia with ECG changes, or hemodynamic compromise
- If used: 100 mEq NaHCO₃ in 400 mL sterile water + 20 mEq KCl over 2 h; reassess after
5. Phosphate
- Routine replacement is not recommended (no evidence of clinical benefit)
- Consider if: phosphate <1 mg/dL, cardiac dysfunction, respiratory depression, or hemolytic anemia
- Use potassium phosphate when replacing (serves dual purpose)
Monitoring
A comprehensive flow sheet tracking the following is essential (Harrison's, p. 11347):
| Parameter | Frequency |
|---|---|
| Blood glucose | Every 1 hour |
| BMP (electrolytes, BUN, Cr) | Every 2–4 hours |
| Venous blood gas | Every 2–4 hours |
| Urine output | Every 1 hour |
| Vital signs | Every 1 hour |
- Continuous cardiac monitoring if K⁺ abnormal
- Reassess for cerebral edema (headache, altered consciousness, bradycardia) — most common in pediatric patients
Resolution Criteria (All Must Be Met)
- Blood glucose <200 mg/dL
- Serum bicarbonate ≥15 mEq/L
- Venous pH >7.3
- Anion gap closed (≤12)
Special Considerations
| Situation | Note |
|---|---|
| SGLT2 inhibitor use | Can cause euglycemic DKA (glucose may be near-normal; don't withhold insulin) |
| Pregnancy | DKA can occur at lower glucose levels; aggressive management; fetal monitoring |
| Children | Higher risk of cerebral edema; slower fluid repletion; strict monitoring |
| Recurrent DKA | Screen for insulin omission, eating disorders, psychosocial barriers |
Precipitating Causes (The "6 I's")
- Infection (most common — pneumonia, UTI)
- Insulin omission/non-compliance
- Infarction (MI, stroke)
- Iatrogenic (steroids, SGLT2 inhibitors, antipsychotics)
- Intoxication (alcohol, cocaine)
- Initial presentation of T1DM
Sources: Harrison's Principles of Internal Medicine, 21st Edition, pp. 11347, 11350
This is a shared conversation. Sign in to Orris to start your own chat.